AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
iSpecimen Inc. Common Stock
XNAS · usd
SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
FIGI BBG00734QDM1
0.82▼ 0.02 (-1.89%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
0.83
Day's Range
0.79 – 0.83
52-Week Range
0.10 – 6.77
Volume
38.4K
Avg Volume
153.9K
Share Statistics
Shares Outstanding
Employees
7
Exchange
XNAS
Listed
2021-06-17
Share count as of August 14, 2026

iSpecimen Inc. Common Stock (ISPC) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about iSpecimen Inc. Common Stock (ISPC)
What is iSpecimen Inc. Common Stock's Market Cap?
iSpecimen Inc. Common Stock's Market Cap is $2.1M, based on as-reported figures from SEC (XBRL) filings.
What is iSpecimen Inc. Common Stock's Price / Sales?
iSpecimen Inc. Common Stock's Price / Sales is 4.4×, based on as-reported figures from SEC (XBRL) filings.
What is iSpecimen Inc. Common Stock's Revenue (TTM)?
iSpecimen Inc. Common Stock's Revenue (TTM) is $466.3K, based on as-reported figures from SEC (XBRL) filings.
What is iSpecimen Inc. Common Stock's Net Income (TTM)?
iSpecimen Inc. Common Stock's Net Income (TTM) is -$11.4M, based on as-reported figures from SEC (XBRL) filings.
What is iSpecimen Inc. Common Stock's EBITDA?
iSpecimen Inc. Common Stock's EBITDA is -$8.2M, based on as-reported figures from SEC (XBRL) filings.
What is iSpecimen Inc. Common Stock's Diluted EPS (TTM)?
iSpecimen Inc. Common Stock's Diluted EPS (TTM) is -4.53, based on as-reported figures from SEC (XBRL) filings.
What is iSpecimen Inc. Common Stock's EBITDA Margin?
iSpecimen Inc. Common Stock's EBITDA Margin is -1762.1%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ISPCAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth-78.7%-85.2%-96.5%-96.0%
Operating expenses:
Cost of revenue
Technology
Sales and marketing
Supply development
Fulfillment
General and administrative
Total operating expenses
% of revenue997.1%1727.1%5292.9%2755.2%
Loss from operations
% of revenue-897.1%-1627.1%-5192.9%-2655.2%
Other income, net
Interest expense——
Interest income
Interest and penalties on sales tax liability
Other income, net
Total other income, net
Net loss and comprehensive loss
% of revenue-896.9%-1458.4%-9662.2%-2608.7%
Net loss per share - basic (in Dollars per share)
Net loss per share - diluted (in Dollars per share)